K.G. Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway.
Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Sci Rep. 2020 Apr 15;10(1):6451. doi: 10.1038/s41598-020-63410-z.
Current studies addressing the influence of interleukin-33 or its receptor (IL-33R/ST2) on development of atopic dermatitis-like inflammation in mice have reported conflicting results. We compared the response in single- and double-deficient IL-33/ST2 C57BL/6J BomTac mice in the well-established calcipotriol-induced model of atopic dermatitis. All genotypes (groups of up to 14 mice) developed atopic dermatitis-like inflammation yet we observed no biologically relevant difference between groups in gross anatomy or ear thickness. Moreover, histological examination of skin revealed no differences in mononuclear leukocyte and granulocyte infiltration nor Th2 cytokine levels (IL-4 and IL-13). Finally, skin CD45+ cells and CD3+ cells were found at similar densities across all groups. Our findings indicate that lack of interleukin-33 and its receptor ST2 does not prevent the development of AD-like skin inflammation.
目前的研究表明白细胞介素-33 或其受体(IL-33R/ST2)对特应性皮炎样炎症在小鼠中的发展有影响,但研究结果相互矛盾。我们比较了在单基因和双基因敲除 IL-33/ST2 C57BL/6J BomTac 小鼠中,在已建立的钙泊三醇诱导的特应性皮炎模型中的反应。所有基因型(每组多达 14 只小鼠)均发展出特应性皮炎样炎症,但我们在大体解剖或耳朵厚度方面未观察到组间存在生物学上的显著差异。此外,皮肤组织学检查显示单核细胞和粒细胞浸润以及 Th2 细胞因子(IL-4 和 IL-13)水平无差异。最后,所有组的皮肤 CD45+细胞和 CD3+细胞密度相似。我们的研究结果表明,缺乏白细胞介素-33 和其受体 ST2 并不能阻止 AD 样皮肤炎症的发展。